(Q36116173)

English

Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 August 2017

Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease (English)

1 reference

Europe PubMed Central

12 August 2017

author name string

Tampellini M

1

1 reference

Europe PubMed Central

12 August 2017

Berruti A

2

1 reference

Europe PubMed Central

12 August 2017

Gerbino A

3

1 reference

Europe PubMed Central

12 August 2017

Buniva T

4

1 reference

Europe PubMed Central

12 August 2017

Torta M

5

1 reference

Europe PubMed Central

12 August 2017

Gorzegno G

6

1 reference

Europe PubMed Central

12 August 2017

Faggiuolo R

7

1 reference

Europe PubMed Central

12 August 2017

Cannone R

8

1 reference

Europe PubMed Central

12 August 2017

Farris A

9

1 reference

Europe PubMed Central

12 August 2017

Destefanis M

10

1 reference

Europe PubMed Central

12 August 2017

Moro G

11

1 reference

Europe PubMed Central

12 August 2017

Deltetto F

12

1 reference

Europe PubMed Central

12 August 2017

Dogliotti L

13

1 reference

Europe PubMed Central

12 August 2017

language of work or name

0 references

publication date

1 January 1997

1 reference

Europe PubMed Central

12 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

12 August 2017

75

1 reference

Europe PubMed Central

12 August 2017

5

1 reference

Europe PubMed Central

12 August 2017

698-702

1 reference

Europe PubMed Central

12 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1997.124

0 references

Chemotherapy of advanced breast cancer: outcome and prognostic factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063336

2 October 2017

Tumor markers for breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063336

2 October 2017

A decade of breast cancer clinical investigation: results as reported in the Program/Proceedings of the American Society of Clinical Oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063336

2 October 2017

Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063336

2 October 2017

Breast cancer: chemotherapy in the treatment of advanced disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063336

2 October 2017

Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063336

2 October 2017

Treatment of metastatic breast cancer: present and future prospects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063336

2 October 2017

Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063336

2 October 2017

Cancer mortality in Italy: an overview of age-specific and age-standardised trends from 1955 to 1984.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063336

2 October 2017

Circulating tumor markers in breast cancer (review).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063336

2 October 2017

Human breast cancer: survival from first metastasis. Breast Cancer Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063336

2 October 2017

Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063336

2 July 2018

Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063336

2 July 2018

Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063336

2 July 2018

Objective measurement of therapeutic response in breast cancer using tumour markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063336

2 July 2018

Prognostic factors in metastatic breast cancer treated with combination chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063336

2 July 2018

Clinical course of breast cancer patients with liver metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/9043027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of CA 15-3 and CEA in diagnosis and monitoring of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9043027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of CA-549 with CA 15-3 and MCA in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9043027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CA 15.3 determination in patients with breast cancer: clinical utility for the detection of distant metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/9043027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CA 15-3 in patients with locoregional and metastatic breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9043027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel method for monitoring high-risk breast cancer with tumor markers: CA 15.3 compared to CEA and TPA

1 reference

https://pubmed.ncbi.nlm.nih.gov/9043027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CA 15.3 with urinary calcium excretion is useful in the diagnosis and monitoring of bone metastases from breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9043027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of critical differences of CEA and CA 15.3 levels in serial samples from patients operated for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9043027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/9043027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1997.124

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36116173&oldid=1948114908"